4//SEC Filing
Struthers Richard Scott 4
Accession 0000950170-24-045136
CIK 0001658247other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:30 PM ET
Size
10.3 KB
Accession
0000950170-24-045136
Insider Transaction Report
Form 4
Struthers Richard Scott
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2024-04-15$1.91/sh+20,000$38,200→ 257,835 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-15−20,000→ 81,270 totalExercise: $1.91Exp: 2028-03-16→ Common Stock (20,000 underlying)
Holdings
- 110,000(indirect: By Trust)
Common Stock
- 570,805(indirect: By Trust)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]1/48th of the shares subject to the option vested on April 16, 2018, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001746298
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 4:30 PM ET
- Size
- 10.3 KB